Is Synecore mesh resistant to infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Synecore Mesh Infection Resilience

Synecore mesh demonstrates significant resilience to infection with a low mesh infection rate of only 1.4%, and importantly, no mesh infections requiring full explantation in clinical studies. 1

Mesh Infection Risk Factors

Mesh infection is a serious complication of hernia repairs that occurs in approximately 1.9-5% of cases 2, 3. Several factors increase the risk of mesh infection:

  • Patient-related factors:

    • Steroid or immunosuppressive drug use (OR 2.22) 2
    • Urgent repair (OR 5.06) 2
    • Postoperative surgical site infection (OR 2.9) 2
  • Procedure-related factors:

    • Mesh type (OR 3.13) 2
    • Onlay position (OR 3.51) 2
    • Associated enterotomy during procedure (OR 5.17) 2

Synecore Mesh Performance

Recent evidence specifically evaluating GORE Synecor™ mesh in ventral hernia repair demonstrates:

  • Overall mesh infection rate of only 1.4% 1
  • No mesh infections requiring full explantation 1
  • Low hernia recurrence rate of 5.0% 1
  • Favorable safety profile across various defect sizes and mesh placement locations 1

Mesh Selection in Contaminated Fields

The choice of mesh in contaminated surgical fields has been debated:

  • Traditionally, biological meshes were preferred in contaminated settings due to perceived infection resistance 2
  • Recent evidence shows synthetic meshes may perform equally well or better than biological meshes in contaminated fields 4, 5
  • A 2024 meta-analysis found synthetic mesh had significantly lower recurrence rates compared to biological mesh in contaminated fields, with similar surgical site infection rates 5

Pathogenesis of Mesh Infection

Mesh infection involves complex interactions between:

  • Bacterial virulence
  • Surface physicochemical properties of the prosthetic material
  • Host defense mechanisms 2

The primary concern is biofilm formation, where bacteria become embedded in self-secreted extracellular polymeric substances, creating an effective barrier against host immune cells and antibiotics 2, 6.

Management of Mesh Infections

If mesh infection occurs despite Synecore's resilience:

  1. Conservative management: Early antibiotics and mechanical scrubbing/irrigation to remove biofilm before consolidation 2
  2. Surgical management: If conservative treatment fails, complete surgical removal of the mesh may be necessary to prevent recurrent infections, visceral adhesions, and fistulae 2

Clinical Implications

When considering Synecore mesh for hernia repair:

  • The low infection rate (1.4%) and absence of infections requiring complete mesh removal suggest excellent infection resilience 1
  • Synecore appears to perform well even in higher-risk scenarios, with favorable outcomes across different placement techniques 1
  • Proper surgical technique remains essential to minimize infection risk, including avoiding enterotomy and minimizing operative time 3

Caution

Despite Synecore's promising infection resilience:

  • All mesh materials carry some infection risk as foreign bodies
  • Proper aseptic technique remains critical, as even slight breaches in sterility can lead to biofilm formation 7
  • Early recognition and treatment of mesh-related complications are essential to prevent progression to chronic infection requiring mesh removal 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Complications of Incisional Hernia Repair

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

In vivo biofilm on the surface of a surgical mesh implant.

Polish journal of microbiology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.